172 related articles for article (PubMed ID: 12390306)
21. CTLA-4 regulates induction of anergy in vivo.
Greenwald RJ; Boussiotis VA; Lorsbach RB; Abbas AK; Sharpe AH
Immunity; 2001 Feb; 14(2):145-55. PubMed ID: 11239447
[TBL] [Abstract][Full Text] [Related]
22. B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma.
Van Ginderachter JA; Liu Y; Geldhof AB; Brijs L; Thielemans K; De Baetselier P; Raes G
Int J Cancer; 2000 Aug; 87(4):539-47. PubMed ID: 10918195
[TBL] [Abstract][Full Text] [Related]
23. Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance.
Alenmyr L; Matheu V; Uller L; Greiff L; Malm-Erjefält M; Ljunggren HG; Persson CG; Korsgren M
Scand J Immunol; 2005 Nov; 62(5):437-44. PubMed ID: 16305640
[TBL] [Abstract][Full Text] [Related]
24. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells.
Saverino D; Merlo A; Bruno S; Pistoia V; Grossi CE; Ciccone E
J Immunol; 2002 Jan; 168(1):207-15. PubMed ID: 11751964
[TBL] [Abstract][Full Text] [Related]
25. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
26. Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.
Sakurai J; Ohata J; Saito K; Miyajima H; Hirano T; Kohsaka T; Enomoto S; Okumura K; Azuma M
J Immunol; 2000 Jan; 164(2):664-9. PubMed ID: 10623808
[TBL] [Abstract][Full Text] [Related]
27. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression.
Melamed D; Friedman A
Eur J Immunol; 1994 Sep; 24(9):1974-81. PubMed ID: 8088317
[TBL] [Abstract][Full Text] [Related]
28. The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration.
Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
Int Immunol; 1999 Dec; 11(12):1881-8. PubMed ID: 10590253
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade enhances incidence and severity of experimental autoimmune neuritis in resistant mice.
Zhu J; Zou L; Zhu S; Mix E; Shi F; Wang H; Volkmann I; Winblad B; Schalling M; Ljunggren H
J Neuroimmunol; 2001 Apr; 115(1-2):111-7. PubMed ID: 11282160
[TBL] [Abstract][Full Text] [Related]
30. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
31. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
Blazevic V; Trubey CM; Shearer GM
J Clin Immunol; 2001 Jul; 21(4):293-302. PubMed ID: 11506200
[TBL] [Abstract][Full Text] [Related]
33. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite.
Lu P; Zhou X; Chen SJ; Moorman M; Morris SC; Finkelman FD; Linsley P; Urban JF; Gause WC
J Exp Med; 1994 Aug; 180(2):693-8. PubMed ID: 8046343
[TBL] [Abstract][Full Text] [Related]
34. Unresponsive CD4+ T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7-1/CTLA-4 molecular pathway.
Gomes NA; Barreto-de-Souza V; Wilson ME; DosReis GA
J Infect Dis; 1998 Dec; 178(6):1847-51. PubMed ID: 9815249
[TBL] [Abstract][Full Text] [Related]
35. The role of CTLA-4 in regulating Th2 differentiation.
Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
[TBL] [Abstract][Full Text] [Related]
36. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation.
Kato T; Nariuchi H
J Immunol; 2000 Apr; 164(7):3554-62. PubMed ID: 10725710
[TBL] [Abstract][Full Text] [Related]
37. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
38. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
Frauwirth KA; Alegre ML; Thompson CB
J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
[TBL] [Abstract][Full Text] [Related]
39. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.
Shrikant P; Khoruts A; Mescher MF
Immunity; 1999 Oct; 11(4):483-93. PubMed ID: 10549630
[TBL] [Abstract][Full Text] [Related]
40. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
Krummel MF; Allison JP
J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
